Full Press Release Details
Media
• February 23, 2024
IRWD Positive Sentiment
Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference
Key Takeaway: Ironwood Pharmaceuticals announced its participation in the ASPEN 2024 Nutrition Science & Practice Conference, where it will present four abstracts. This involvement underscores the company's dedication to advancing research in nutrition science. The conference serves as a significant platform for sharing innovative findings in the field.
Price reaction · baseline $14.86 (2024-02-22 close) · hit after-hours · clean, no other IRWD news in the window
day 0 close · peak
+1.4%
Market Sentiment Analysis
POSITIVE FACTORS
- Ironwood Pharmaceuticals is actively participating in a key conference.
- Presentation of four abstracts highlights the company's research efforts.
- Engagement in the ASPEN 2024 Conference showcases commitment to nutrition science.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+57%
120-day peak, hindsight
Typical move
3.8%
average across 2 past catalysts
Lead asset
IW-3718
Phase 3 · Gastroesophageal Reflux Disease (GERD)
Frequently Asked Questions
What is the ASPEN 2024 Conference?
The ASPEN 2024 Conference focuses on nutrition science and practice.
How many abstracts will Ironwood present?
Ironwood Pharmaceuticals will present four abstracts at the conference.
What is the significance of Ironwood's participation?
Ironwood's participation highlights its commitment to advancing nutrition science.
When will the ASPEN 2024 Conference take place?
The conference is scheduled for February 2024.